JPMorgan Chase & Co. Issues Pessimistic Forecast for McCormick & Company, Incorporated (NYSE:MKC) Stock Price

McCormick & Company, Incorporated (NYSE:MKC) had its target price reduced by equities researchers at JPMorgan Chase & Co. from $67.00 to $64.00 in a research note issued on Wednesday,Benzinga reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price would suggest a potential upside of 32.85% from the company’s previous close.

Several other analysts also recently commented on the stock. HSBC reduced their target price on shares of McCormick & Company, Incorporated from $69.00 to $55.00 and set a “hold” rating for the company in a report on Thursday, March 26th. Jefferies Financial Group cut their price objective on shares of McCormick & Company, Incorporated from $81.00 to $64.00 and set a “buy” rating for the company in a research report on Wednesday. BNP Paribas Exane reduced their price objective on McCormick & Company, Incorporated from $83.00 to $75.00 and set an “outperform” rating for the company in a report on Wednesday. TD Cowen decreased their target price on McCormick & Company, Incorporated from $75.00 to $64.00 and set a “buy” rating on the stock in a research report on Wednesday, March 25th. Finally, Sanford C. Bernstein lowered their target price on McCormick & Company, Incorporated from $85.00 to $77.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 24th. Six equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $64.27.

McCormick & Company, Incorporated Stock Performance

McCormick & Company, Incorporated stock traded down $2.26 during mid-day trading on Wednesday, hitting $48.18. 11,359,872 shares of the company’s stock traded hands, compared to its average volume of 4,188,659. The firm has a 50 day simple moving average of $63.01 and a two-hundred day simple moving average of $65.27. McCormick & Company, Incorporated has a fifty-two week low of $48.05 and a fifty-two week high of $82.90. The stock has a market cap of $12.93 billion, a price-to-earnings ratio of 16.44, a P/E/G ratio of 3.15 and a beta of 0.58. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.70 and a quick ratio of 0.28.

McCormick & Company, Incorporated (NYSE:MKC) last released its quarterly earnings data on Tuesday, March 31st. The company reported $0.66 EPS for the quarter, beating the consensus estimate of $0.61 by $0.05. The firm had revenue of $1.87 billion for the quarter, compared to the consensus estimate of $1.79 billion. McCormick & Company, Incorporated had a net margin of 11.54% and a return on equity of 14.27%. The company’s quarterly revenue was up 16.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.60 earnings per share. On average, research analysts expect that McCormick & Company, Incorporated will post 3.07 EPS for the current fiscal year.

Insider Buying and Selling

In related news, major shareholder Lawrence Erik Kurzius sold 50,000 shares of the company’s stock in a transaction dated Tuesday, January 13th. The shares were sold at an average price of $67.43, for a total transaction of $3,371,500.00. Following the completion of the sale, the insider owned 246,762 shares of the company’s stock, valued at $16,639,161.66. This represents a 16.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Michael D. Mangan sold 5,000 shares of the stock in a transaction dated Monday, February 9th. The stock was sold at an average price of $67.92, for a total transaction of $339,600.00. Following the sale, the director owned 43,029 shares in the company, valued at $2,922,529.68. The trade was a 10.41% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 115,000 shares of company stock worth $7,947,300. Company insiders own 10.60% of the company’s stock.

Hedge Funds Weigh In On McCormick & Company, Incorporated

Hedge funds and other institutional investors have recently made changes to their positions in the company. Elevation Point Wealth Partners LLC acquired a new stake in shares of McCormick & Company, Incorporated during the 2nd quarter worth approximately $27,000. Heartwood Wealth Advisors LLC acquired a new position in McCormick & Company, Incorporated during the third quarter valued at approximately $28,000. GoalVest Advisory LLC acquired a new position in McCormick & Company, Incorporated during the fourth quarter valued at approximately $28,000. Deseret Mutual Benefit Administrators lifted its stake in McCormick & Company, Incorporated by 67.8% during the fourth quarter. Deseret Mutual Benefit Administrators now owns 406 shares of the company’s stock worth $28,000 after purchasing an additional 164 shares during the last quarter. Finally, Motiv8 Investments LLC bought a new stake in McCormick & Company, Incorporated during the fourth quarter worth $28,000. 79.74% of the stock is currently owned by institutional investors and hedge funds.

Key Headlines Impacting McCormick & Company, Incorporated

Here are the key news stories impacting McCormick & Company, Incorporated this week:

• Positive Sentiment: Q1 beat and healthy revenue growth: McCormick delivered $0.66 EPS vs. $0.61 expected and reported revenue up ~16.7% Y/Y, driven by acquisitions, pricing and margin improvement — evidence of operational strength that supports near-term fundamentals. Q1 metrics vs. estimates
• Positive Sentiment: Strategic scale from Unilever foods tie-up: The announced combination with Unilever’s foods business creates a much larger flavor/foods platform with stated cost synergies (~$600M run-rate) and revenue scale — a long-term growth and margin story if regulators and integration go smoothly. Press release
• Positive Sentiment: Some analysts remain constructive: BNP Paribas Exane and Jefferies still carry Outperform/Buy stances with meaningful upside to their revised targets, signaling belief in the deal’s longer-term value despite shorter-term uncertainty. BNP Paribas / Jefferies coverage Jefferies PT change
• Neutral Sentiment: Heightened trading activity and options volume: Large option flows and elevated share volume indicate speculative positioning and increased volatility around the deal/earnings news — watch implied volatility and block trades for near-term swing risk.
• Neutral Sentiment: Market positioning/value narrative: Several outlets note MKC is trading at value levels that could appeal to income investors (high dividend yield relative to history) — potential for bargain-hunting if risk appetite returns. MarketBeat value note
• Negative Sentiment: Widespread analyst price-target cuts: Multiple firms trimmed targets (Stifel to $55, Barclays to $58, others lowered) which reduces near-term sentiment and gives less analyst support for the current price level. Stifel PT cut Barclays/Benzinga
• Negative Sentiment: Shareholder legal notices and investigations: Several firms have issued shareholder alerts and investigations into whether the transaction is fair to McCormick shareholders — this increases execution risk, potential delay and legal expense. KSF investor alert Ademi alert
• Negative Sentiment: Market skepticism on deal mechanics and dilution: Banks and some analysts warn the structure is complex and could dilute shareholders; that skepticism triggered the initial sell-off and remains the primary driver of downward pressure. Analyst/market reaction

McCormick & Company, Incorporated Company Profile

McCormick & Company, Incorporated (NYSE: MKC) is a global leader in spices, seasonings and flavor solutions. Headquartered in Hunt Valley, Maryland, the company traces its origins to the late 19th century and has grown into a major manufacturer and marketer of branded and private‑label flavor products for consumer, industrial and foodservice markets.

McCormick’s product portfolio includes pure spices and herbs, blended seasonings, marinades, rubs, sauces, extracts and specialty flavorings, along with ingredient systems and custom flavor development for manufacturers and foodservice operators.